Core Insights - Corteva, Inc. reported revenue of $3.91 billion for the quarter ended December 2025, reflecting a 1.7% decline year-over-year and a surprise of -7.49% compared to the Zacks Consensus Estimate of $4.23 billion [1] - The company's EPS was $0.22, down from $0.32 in the same quarter last year, with a positive surprise of +3.14% over the consensus estimate of $0.21 [1] Revenue Performance - Crop Protection revenue was $2.17 billion, below the average estimate of $2.41 billion, marking a year-over-year decrease of -1.5% [4] - Seed revenue totaled $1.74 billion, also below the average estimate of $1.82 billion, with a year-over-year decline of -2% [4] - Revenue from Seed-Other oilseeds was $94 million, exceeding the estimate of $89.86 million, representing an increase of +8.1% year-over-year [4] - Crop Protection revenue from Biologicals was $191 million, slightly above the estimate of $186.79 million [4] - Herbicides revenue was $1.06 billion, below the estimate of $1.14 billion, but showed a year-over-year increase of +3% [4] - Insecticides revenue was $488 million, below the estimate of $557.11 million, reflecting a year-over-year change of -0.4% [4] - Fungicides revenue was $272 million, significantly below the estimate of $357.43 million, with a year-over-year decline of -15% [4] - Other Crop Protection revenue was $160 million, below the estimate of $213.87 million, representing a year-over-year decrease of -18.4% [4] - Seed revenue from Soybean was $164 million, exceeding the estimate of $155.13 million, with a year-over-year increase of +6.5% [4] - Seed revenue from Corn was $1.39 billion, slightly below the estimate of $1.41 billion, reflecting a -1.8% change year-over-year [4] - Seed revenue from Other was $93 million, significantly below the estimate of $138.89 million, with a year-over-year decline of -22.5% [4] - Operating EBITDA for Seed was $124 million, above the average estimate of $103.5 million [4] Stock Performance - Corteva, Inc. shares have returned +7.9% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

分组1 - Corteva, Inc. reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.21 per share, but down from $0.32 per share a year ago, representing an earnings surprise of +3.14% [1] - The company posted revenues of $3.91 billion for the quarter ended December 2025, missing the Zacks Consensus Estimate by 7.49%, compared to $3.98 billion in the same quarter last year [2] - Corteva, Inc. shares have increased approximately 9.2% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.12 on revenues of $4.65 billion, and for the current fiscal year, it is $3.61 on revenues of $18.47 billion [7] - The Agriculture - Operations industry, to which Corteva belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Financial Performance - Net sales for Q4 2025 were $3,910 million, a decrease of 1.7% from $3,978 million in Q4 2024; total net sales for 2025 reached $17,401 million, up 2.9% from $16,908 million in 2024[2] - Net income attributable to Corteva for 2025 was $1,094 million, a 20.6% increase from $907 million in 2024; however, Q4 2025 showed a net loss of $552 million compared to a loss of $41 million in Q4 2024[2] - Basic earnings per share from continuing operations for 2025 was $1.75, up from $1.23 in 2024; Q4 2025 reported a loss per share of $0.80 compared to a loss of $0.08 in Q4 2024[2] - The company reported a net loss from discontinued operations of $99 million for 2025, compared to a gain of $56 million in 2024, impacting overall profitability[2] - The total operating earnings for 2025 were reported at $2,276 million, with an EPS of $3.34, compared to $1,788 million and an EPS of $2.57 in 2024[38] - Operating Earnings for Q4 2025 were $151 million, compared to $221 million in Q4 2024, with full year earnings rising to $2,276 million from $1,788 million[41] - Operating Earnings Per Share (EPS) for Q4 2025 was $0.22, down from $0.32 in Q4 2024, while the full year EPS increased to $3.34 from $2.57[41] Expenses and Investments - Research and development expenses increased to $413 million in Q4 2025 from $365 million in Q4 2024, totaling $1,474 million for the year, compared to $1,402 million in 2024[2] - Capital expenditures for 2025 were $591 million, slightly down from $597 million in 2024, reflecting continued investment in growth initiatives[6] - The company incurred $(434) million in amortization of intangibles for 2025, impacting the EPS by $(0.64)[38] Assets and Liabilities - Total assets increased to $42,845 million in 2025 from $40,825 million in 2024, driven by higher cash and cash equivalents, which rose to $4,521 million from $3,106 million[4] - Total current liabilities rose to $12,125 million in 2025, up from $10,386 million in 2024, primarily due to increases in accounts payable and deferred revenue[4] - Corteva's total stockholders' equity increased to $24,144 million in 2025 from $23,789 million in 2024, indicating a strengthening balance sheet[4] Cash Flow - Cash provided by operating activities for 2025 was $3,406 million, significantly higher than $2,145 million in 2024, indicating improved operational efficiency[6] - Free Cash Flow for the twelve months ended December 31, 2025, was $2,866 million, significantly up from $1,699 million in 2024[52] Segment Performance - Seed segment net sales for the three months ended December 31, 2025, were $1,737 million, down from $1,772 million in 2024, with corn sales at $1,386 million[8] - Crop protection segment net sales for the three months ended December 31, 2025, were $2,173 million, slightly down from $2,206 million in 2024, with herbicides contributing $1,062 million[8] - The Seed product line reported a total net sales increase of $353 million, or 4%, with organic sales up by $453 million, or 5%[25] - In the Crop Protection product line, herbicides saw a net sales increase of $31 million, or 3%, while insecticides and fungicides experienced declines of $2 million and $48 million, respectively[19] - North America seed sales decreased by 15% to $545 million for the three months ended December 31, 2025, compared to $639 million in 2024[8] Significant Items and Charges - The company reported a significant item charge of $602 million for the three months ended December 31, 2025, impacting overall financial performance[10] - Significant items before income taxes totaled $(602) million for the three months ended December 31, 2025, compared to $(18) million in the same period of 2024[28] - The fourth quarter of 2025 reported a significant charge of $(610) million related to the resolution of litigation with Bayer, contributing to an EPS impact of $(0.70) per share[29] - In 2025, the total pre-tax significant items amounted to $(658) million, with an after-tax impact of $(582) million, resulting in an EPS impact of $(0.85) per share[29] Tax and Interest - The effective income tax rate (GAAP) for the full year 2025 was 28.7%, compared to 32.3% in 2024[45] - The base income tax rate from continuing operations for Q4 2025 was 22.0%, slightly down from 23.1% in Q4 2024, with a full year rate of 22.2% compared to 22.8%[41] - Interest income for Q4 2025 was $44 million, up from $39 million in Q4 2024, while interest expense decreased to $46 million from $60 million[41] Currency Impact - The company experienced a currency impact of $(88) million on net sales for the three months ended December 31, 2025[10] - Pre-tax exchange losses for the twelve months ended December 31, 2025, totaled $181 million, compared to $284 million in 2024[49] - The company reported a net after-tax exchange loss of $62 million for Q4 2025, compared to a loss of $43 million in Q4 2024[49]

1. Organic Sales, Operating EPS, Free Cash Flow, and Operating EBITDA are non-GAAP measures. See page 6 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 7 for further discussion. 4. Not meaningful. INDIANAPOLIS, Feb. 3, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for th ...

Key Takeaways CTVA is seeing strong performance in Crop Protection, driven by new products and volume growth.Corteva's Seed segment benefits from advanced genetics, higher out-licensing and execution across key markets.CTVA faces near-term risks from weak crop prices, pressured farm incomes and macro headwinds.Corteva, Inc. (CTVA) is slated to report fourth-quarter 2025 results on Feb. 3, after market close. The company is likely to report a bottom-line decline when it posts the quarterly results.The Zacks ...

Core Insights - Corteva, Inc. (CTVA) is expected to report quarterly earnings of $0.21 per share, reflecting a decline of 34.4% year-over-year, while revenues are forecasted to reach $4.23 billion, indicating a 6.3% increase compared to the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 3.3%, indicating a collective reassessment by analysts of their initial forecasts [2] - Revisions to earnings projections are crucial for predicting investor behavior, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3] Revenue Projections - Analysts estimate 'Revenue- Crop Protection' to be $2.42 billion, a year-over-year increase of 9.8% [5] - 'Revenue- Seed' is projected to reach $1.82 billion, reflecting a 2.6% increase year-over-year [5] - 'Revenue- Seed- Other oilseeds' is expected to be $89.86 million, indicating a 3.3% increase from the previous year [5] Segment Analysis - 'Revenue- Crop Protection- Herbicides' is forecasted at $1.14 billion, a 10.9% increase year-over-year [6] - 'Revenue- Crop Protection- Insecticides' is expected to reach $557.11 million, reflecting a 13.7% increase [6] - 'Revenue- Crop Protection- Fungicides' is projected at $357.43 million, indicating an 11.7% year-over-year change [6] Additional Revenue Insights - 'Revenue- Crop Protection- Other' is estimated at $213.87 million, a 9.1% increase year-over-year [7] - 'Revenue- Seed- Soybean' is expected to be $155.13 million, showing a slight increase of 0.7% [7] - 'Revenue- Seed- Corn' is projected to reach $1.41 billion, indicating a minor decline of 0.1% [7] Operating Metrics - 'Operating EBITDA- Seed' is expected to be $106.13 million, compared to $93.00 million from the previous year [8] - 'Operating EBITDA- Crop Protection' is projected at $430.49 million, down from $461.00 million year-over-year [8] Market Performance - Corteva, Inc. shares have returned +9% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.8% change [9] - The company holds a Zacks Rank 1 (Strong Buy), indicating expectations to outperform the overall market in the near future [9]

Core Insights - Hardman Johnston Global Equity Strategy reported a return of 2.91% for Q4 2025, underperforming the MSCI AC World Net Index which gained 3.29% [1] - The Financials and Consumer Staples sectors contributed positively to performance, while the Industrials and Consumer Discretionary sectors detracted from it [1] Company Summary: Corteva, Inc. (NYSE:CTVA) - Corteva, Inc. operates in the Seed and Crop Protection segments, with a one-month return of 8.91% and a 12.31% increase over the last 52 weeks [2] - As of January 27, 2026, Corteva's stock closed at $73.00 per share, with a market capitalization of $49.33 billion [2] Investment Decision on Corteva, Inc. - The company liquidated its position in Corteva, Inc. due to management's commentary on a potential separation of its Seeds and Crop Protection businesses, which raised concerns about value creation [3] - The Seeds business, accounting for approximately two-thirds of profits, may command a premium multiple, but this could be offset by a lower valuation for the Chemicals business, limiting net value unlock [3] - Strategic credibility concerns arose from the separation narrative, which contradicted previous management messaging about the complementary nature of Seeds and Chemicals [3] - Deteriorating agricultural fundamentals, such as increased U.S. corn acreage and challenges in soybean markets, could pressure farmer spending on inputs [3] - The combination of elevated valuation, strategic uncertainty, and weakening agricultural fundamentals led to the decision to exit the position in Corteva, Inc. [3]

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Corteva, Inc. (CTVA) despite an increase in revenues when it reports its results for the quarter ended December 2025 [1] Earnings Expectations - Corteva is expected to report quarterly earnings of $0.21 per share, reflecting a year-over-year decrease of 34.4% [3] - Revenues are projected to be $4.23 billion, which is an increase of 6.4% compared to the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 6.5% over the last 30 days, indicating a reassessment by analysts regarding the company's earnings prospects [4] - The Most Accurate Estimate for Corteva is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -2.57% [12] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictive power for positive readings [9][10] - Corteva currently holds a Zacks Rank of 1, but the negative Earnings ESP complicates predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Corteva was expected to post a loss of $0.49 per share but instead reported a loss of -$0.23, resulting in a positive surprise of 53.06% [13] - Over the past four quarters, Corteva has beaten consensus EPS estimates three times [14] Conclusion - While Corteva does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of its earnings release [17]

Core Viewpoint - Corteva Inc (NYSE:CTVA) is recognized as a strong investment opportunity in the materials sector, with analysts from JPMorgan and Mizuho Securities raising their price targets, indicating potential upside for investors [1][3]. Group 1: Analyst Ratings and Price Targets - Jeffrey Zekauskas from JPMorgan maintained an Overweight rating on Corteva and increased the price target from $70 to $75, suggesting an upside of nearly 9% [1]. - Edlain Rodriguez from Mizuho Securities raised his price target for Corteva from $78 to $80, resulting in an upside of over 16% from the current level [3][4]. Group 2: Revenue Expectations - Zekauskas attributed his price target increase to anticipated higher U.S. corn volumes in 2026, estimating that a 100 basis points increase in global corn volume could yield approximately $70 million in revenues for Corteva, while an increase of 1 million acres of corn volume could lead to around $100 million in sales [2]. Group 3: Company Overview - Corteva Inc operates as a pure-play agriculture business, providing seed, crop protection, and digital agriculture solutions aimed at enhancing crop yields through innovation, focusing on herbicides, insecticides, fungicides, and biologicals [5].

Industry Overview - The AgTech and food innovation sector is experiencing significant transformation as technology adoption accelerates in farming, food production, and distribution, focusing on sustainability and efficiency [1] - Structural pressures such as climate volatility, labor constraints, and rising input costs are driving the need for innovation, with consumers increasingly favoring transparency and responsible sourcing [2] Digitization and Technological Advancements - A major trend is the digitization of farm operations, with precision agriculture, connected machinery, and real-time analytics optimizing yields while minimizing waste [3] - Companies like Deere & Company are central to this shift, utilizing GPS-guided equipment and data platforms to enhance productivity [3] Food Innovation Trends - Food innovation is evolving as producers adapt to health-oriented diets and sustainability considerations, influencing product development strategies [4] - Tyson Foods is investing in alternative proteins and automation to align its offerings with long-term consumer trends [4] Investment Opportunities - The AgTech and Food Innovation sector presents compelling investment opportunities as companies balance short-term volatility with long-term necessity [5] - Key players such as Corteva, Beyond Meat, and Ingredion are highlighted for their alignment with trends in precision agriculture and protein demand [6] Company Insights: Corteva - Corteva is positioned as a leader in AgTech, focusing on advanced seed genetics and crop protection solutions to meet rising demand driven by climate variability and pest pressures [7] - The company is rolling out new hybrids and investing in gene editing technologies to accelerate innovation [8] - Corteva's initiatives include developing environmentally aligned crop protection solutions, reinforcing its role in the AgTech ecosystem [9] Company Insights: Ingredion - Ingredion is focusing on clean-label ingredients and functional nutrition, responding to inflation and shifting consumer preferences [11] - The company's Texture & Healthful Solutions segment is experiencing solid growth, particularly in clean-label ingredients and protein fortification [12] - Ingredion is also advancing food innovation through targeted solution development and technology adoption, including sugar reduction technologies [13] Company Insights: Beyond Meat - Beyond Meat is adapting to changing protein consumption patterns by focusing on health, sustainability, and resource efficiency [14] - The company is enhancing the nutritional quality of its plant-based proteins, aligning with consumer demand for transparency [15] - Beyond Meat's innovation strategy includes faster product iteration through the Beyond Test Kitchen and ongoing supply-chain improvements [16]